Auriga Laboratories, a specialty pharmaceutical company announced the launch of Coraz Lotion (hydrocortisone lotion USP, 2%) indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as Seborrheic Dermatitis.